Inflammatory biomarkers for persistent fatigue in breast cancer survivors
- PMID: 16675568
- DOI: 10.1158/1078-0432.CCR-05-2398
Inflammatory biomarkers for persistent fatigue in breast cancer survivors
Abstract
Purpose: This study seeks to define immunologic and inflammatory variables associated with persistent post-treatment fatigue in breast cancer survivors.
Experimental design: Leukocyte subsets, plasma inflammatory markers, and ex vivo proinflammatory cytokine production were assessed in 50 fatigued and nonfatigued breast cancer survivors recruited > or = 2 years after successful primary therapy. Multivariate statistical analyses were used to define a composite immunologic biomarker of fatigue risk.
Results: Fatigued breast cancer survivors were distinguished from nonfatigued survivors by increased ex vivo monocyte production of interleukin (IL)-6 and tumor necrosis factor-alpha following lipopolysaccharide stimulation, elevated plasma IL-1ra and soluble IL-6 receptor (sIL-6R/CD126), decreased monocyte cell-surface IL-6R, and decreased frequencies of activated T lymphocytes and myeloid dendritic cells in peripheral blood (all P < 0.05). An inverse correlation between sIL-6R and cell-surface IL-6R was consistent with inflammation-mediated shedding of IL-6R, and in vitro studies confirmed that proinflammatory cytokines induced such shedding. Multivariate linear discriminant function analysis identified two immunologic markers, the ratio of sIL-6R to monocyte-associated IL-6R and decreased circulating CD69+ T lymphocytes, as highly diagnostic of fatigue (P = 0.0005), with cross-validation estimates indicating 87% classification accuracy (sensitivity = 0.83; specificity = 0.83).
Conclusion: These results extend links between fatigue and inflammatory markers to show a functional alteration in proinflammatory cytokine response to lipopolysaccharide and define a prognostic biomarker of behavioral fatigue.
Similar articles
-
Inflammatory responses to psychological stress in fatigued breast cancer survivors: relationship to glucocorticoids.Brain Behav Immun. 2007 Mar;21(3):251-8. doi: 10.1016/j.bbi.2006.08.001. Epub 2006 Sep 27. Brain Behav Immun. 2007. PMID: 17008048
-
Higher levels of fatigue are associated with higher CRP levels in disease-free breast cancer survivors.J Psychosom Res. 2011 Sep;71(3):136-41. doi: 10.1016/j.jpsychores.2011.04.003. Epub 2011 May 18. J Psychosom Res. 2011. PMID: 21843747
-
Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.Transplantation. 2003 Apr 27;75(8):1351-5. doi: 10.1097/01.TP.0000063706.52369.ED. Transplantation. 2003. PMID: 12717229
-
The relationship between testosterone and molecular markers of inflammation in older men.J Endocrinol Invest. 2005;28(11 Suppl Proceedings):116-9. J Endocrinol Invest. 2005. PMID: 16760639 Review.
-
Cancer related fatigue: a focus on breast cancer and Hodgkin's disease survivors.Acta Oncol. 2007;46(4):474-9. doi: 10.1080/02841860701367845. Acta Oncol. 2007. PMID: 17497314 Review.
Cited by
-
SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.Lung Cancer. 2012 Jul;77(1):217-23. doi: 10.1016/j.lungcan.2012.02.017. Epub 2012 Mar 29. Lung Cancer. 2012. PMID: 22464751 Free PMC article.
-
Mechanisms of chemotherapy-induced behavioral toxicities.Front Neurosci. 2015 Apr 21;9:131. doi: 10.3389/fnins.2015.00131. eCollection 2015. Front Neurosci. 2015. PMID: 25954147 Free PMC article. Review.
-
Factors predicting clinically significant fatigue in women following treatment for primary breast cancer.Support Care Cancer. 2011 Oct;19(10):1581-91. doi: 10.1007/s00520-010-0986-7. Epub 2010 Sep 12. Support Care Cancer. 2011. PMID: 20835835 Free PMC article.
-
The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.Front Psychol. 2022 Jun 21;13:920556. doi: 10.3389/fpsyg.2022.920556. eCollection 2022. Front Psychol. 2022. PMID: 35800955 Free PMC article. Review.
-
DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.Leuk Lymphoma. 2019 Jun;60(6):1429-1437. doi: 10.1080/10428194.2018.1533128. Epub 2019 Jan 22. Leuk Lymphoma. 2019. PMID: 30668190 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials